Inhibition mechanism of SARS-CoV-2 main protease by ebselen and its derivatives.
Inhibition mechanism of SARS-CoV-2 main protease by ebselen and its derivatives.
复制标题
DOI:
10.1038/s41467-021-23313-7
复制
发表时间:
2021-05-24
影响因子:
16.6
通讯作者:
Samar Hasnain S
中科院分区:
文献类型:
--
作者:
Amporndanai K;Meng X;Shang W;Jin Z;Rogers M;Zhao Y;Rao Z;Liu ZJ;Yang H;Zhang L;O'Neill PM;Samar Hasnain S
The SARS-CoV-2 pandemic has triggered global efforts to develop therapeutics. The main protease of SARS-CoV-2 (Mpro), critical for viral replication, is a key target for therapeutic development. An organoselenium drug called ebselen has been demonstrated to have potent Mpro inhibition and antiviral activity. We have examined the binding modes of ebselen and its derivative in Mpro via high resolution co-crystallography and investigated their chemical reactivity via mass spectrometry. Stronger Mpro inhibition than ebselen and potent ability to rescue infected cells were observed for a number of derivatives. A free selenium atom bound with cysteine of catalytic dyad has been revealed in crystallographic structures of Mpro with ebselen and MR6-31-2 suggesting hydrolysis of the enzyme bound organoselenium covalent adduct and formation of a phenolic by-product, confirmed by mass spectrometry. The target engagement with selenation mechanism of inhibition suggests wider therapeutic applications of these compounds against SARS-CoV-2 and other zoonotic beta-corona viruses. Ebselen is an organoselenium drug that inhibits the SARS-CoV-2 main protease (Mpro). Here, the authors co-crystallised Mpro with ebselen and an ebselen derivative and observed an enzyme bound organoselenium covalent adduct in the crystal structures, which was also confirmed by mass spectrometry analysis.
登录
查看更多内容
影响因子:
16.8
作者:
Jin, Zhenming;Zhao, Yao;Rao, Zihe
通讯作者:
Rao, Zihe
DOI:
10.1107/s090744491003982x
发表时间:
2011-04
期刊:
Acta crystallographica. Section D, Biological crystallography
影响因子:
--
作者:
Evans PR
通讯作者:
Evans PR
影响因子:
64.8
作者:
Plante JA;Liu Y;Liu J;Xia H;Johnson BA;Lokugamage KG;Zhang X;Muruato AE;Zou J;Fontes-Garfias CR;Mirchandani D;Scharton D;Bilello JP;Ku Z;An Z;Kalveram B;Freiberg AN;Menachery VD;Xie X;Plante KS;Weaver SC;Shi PY
通讯作者:
Shi PY
影响因子:
3.4
作者:
Sharpley AL;Williams C;Holder AA;Godlewska BR;Singh N;Shanyinde M;MacDonald O;Cowen PJ
通讯作者:
Cowen PJ
影响因子:
16.6
作者:
Douangamath A;Fearon D;Gehrtz P;Krojer T;Lukacik P;Owen CD;Resnick E;Strain-Damerell C;Aimon A;Ábrányi-Balogh P;Brandão-Neto J;Carbery A;Davison G;Dias A;Downes TD;Dunnett L;Fairhead M;Firth JD;Jones SP;Keeley A;Keserü GM;Klein HF;Martin MP;Noble MEM;O'Brien P;Powell A;Reddi RN;Skyner R;Snee M;Waring MJ;Wild C;London N;von Delft F;Walsh MA
通讯作者:
Walsh MA